Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
Revenue Performance
Above historical average, strong compound growth.
Left:
||||
Total revenue from sales of goods and services
Latest
$14.20B
↑ 54% above average
Average (9y)
$9.22B
Historical baseline
Range
High:$16.07B
Low:$4.10B
CAGR
+14.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $14.20B | +8.3% |
| 2023 | $13.12B | +7.8% |
| 2022 | $12.17B | -24.3% |
| 2021 | $16.07B | +89.1% |
| 2020 | $8.50B | +29.6% |
| 2019 | $6.56B | -2.3% |
| 2018 | $6.71B | +14.3% |
| 2017 | $5.87B | +20.8% |
| 2016 | $4.86B | +18.4% |
| 2015 | $4.10B | - |